King George's Medical University is a medical school, hospital, and medical university located in Lucknow, Uttar Pradesh, India. The medical school was raised to a medical university by an act passed by the government of Uttar Pradesh on 16 September 2002.

During the past decade, King George's Medical University conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "King George's Medical University" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Pharmazz, Inc." with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "King George's Medical University" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "United States Agency for International Development (USAID)" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "King George's Medical University" are "Crohn's Disease" (3 trials), "Panuveitis" (3 trials), "Ulcerative Colitis" (3 trials), "Rheumatoid Arthritis" (2 trials) and "Uveitis" (2 trials). Many other conditions were trialed in "King George's Medical University" in a lesser frequency.

Most popular intervention types in "King George's Medical University" are "Drug" (31 trials), "Biological" (4 trials), "Behavioral" (3 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Filgotinib" (2 trials), "Guselkumab" (2 trials), "Mirikizumab" (2 trials) and "Normal Saline along with standard treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "King George's Medical University" are 42 trials for "All" genders.

Currently, there are NaN active trials in "King George's Medical University". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 27 completed trials in King George's Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in King George's Medical University, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

King George's Medical University has several departments that took part in Clinical trials: "Department of Urology, King George's Medical University, Lucknow, UP, India" - 2 trials, "Department of Critical Care Medicine" - 2 trials